How to Sell a Veterinary Practice in 2026: The Complete Process Guide

Key takeaways

• A vet practice sale typically takes 5 to 10 months from advisor engagement to closing, with the highest-impact valuations supported by 12 to 24 months of practice preparation before going to market.
• The 7-step process: document normalized EBITDA, decide your timeline and goals, prepare the practice operationally, build the right buyer pool, run a structured competitive process, negotiate the winning offer, close the transaction.
• The single biggest variable in your outcome is whether you run a structured competitive process or accept a direct offer from one buyer — the difference reliably runs into millions of dollars on any meaningful practice.
• The single biggest mistake first-time sellers make is signing exclusivity with the first buyer who calls, which forfeits the leverage that competition provides.
• The 18-to-24 month preparation window is where the highest-ROI improvements get made: adding associates to diversify clinical production, building real management depth, demonstrating growth, and normalizing EBITDA properly.
• The after-tax check is usually meaningfully less than the headline sale price. Coordinating the M&A advisor, CPA, and a transaction-specialist tax attorney early in the process is where the seller’s optimal take-home gets built.

A vet pulled me aside at a conference dinner last year. He’d been thinking about selling his practice for 3 years.

Every time he’d gotten close to engaging an advisor, life had gotten in the way. The associate had quit.

The new associate had taken 6 months to ramp up. The HVAC had failed and the landlord had been impossible.

The equipment lease had needed renegotiation. He was tired.

He asked me one question. If I called you Monday and said let’s go, what would the next 18 months actually look like?

That conversation is what this article is about. The full process of selling a veterinary practice — the timeline, the work, the seven distinct steps from engagement to closing, the preparation that determines where in the multiple range your practice will actually clear, and the mistakes that consistently cost owners money.

This is the process side of the conversation. For what your practice will sell for, see our veterinary practice EBITDA multiples guide.

For how private equity buyers structure their offers, see how much private equity is paying for veterinary practices. For the directory of who’s actually buying, see our veterinary practice consolidators directory.

The realistic timeline

From the engagement of a sell-side advisor to closing the transaction, the typical timeline for a competitive sale process runs 5 to 10 months. Mahan Law’s published guide on the timeline and process for selling a veterinary practice, Total Practice Solutions Group’s commentary, and Capstone Partners’ market materials all describe similar windows.

The breakdown of those 5 to 10 months looks roughly like this. Practice preparation and data room build runs 30 to 45 days.

Buyer pool identification and outreach takes 30 to 60 days. The competitive bidding window where indications of interest come in runs 14 to 60 days.

Negotiation of the winning offer and the letter of intent takes another 14 to 30 days. Due diligence and the definitive purchase agreement run 60 to 90 days.

Final closing logistics and regulatory transfers take 30 to 60 days. Some of these phases overlap.

Each can extend if circumstances require.

Most owners who eventually sell benefit from starting practice preparation 12 to 24 months before going to market. This longer preparation window is where the highest-impact operational improvements get made — adding associates, building management depth, demonstrating growth, normalizing EBITDA properly.

Owners who start preparing 18 months out and then run a 6 to 10 month sale process from there spend roughly 24 to 28 months from “I want to sell” to “deal closed.” Owners who attempt to sell with no preparation typically clear lower multiples than the practice could have supported.

The honest framing for any owner considering a sale: if your target close date is less than 12 months out, you’re working with whatever the practice looks like today. If you have 18 months or more, you have meaningful runway to improve the outcome.

Step 1: Document your normalized EBITDA

Everything downstream is anchored to this number. Anchor wrong and the entire process compounds the error.

The figure on your P&L is not the number buyers will pay against. Per industry valuation literature and M&A commentary, buyers price practices against normalized EBITDA — the earnings figure after stripping out personal expenses you run through the practice, family members on payroll above market rate, one-time costs, and owner compensation above what a hired medical director would cost.

Documented normalization typically raises the EBITDA number 15 to 30 percent above the raw P&L figure, per industry M&A commentary.

A practice showing $620,000 of P&L EBITDA might support a defensible normalized number of $810,000 after proper documentation — a 31 percent lift. On a 10-times multiple, that gap is roughly $1.9 million of sale price that gets left on the table when owners anchor to the wrong number.

The work to build normalized EBITDA properly isn’t a casual exercise. Most veterinary practice CPAs do excellent tax work and aren’t trained for the kind of normalization a sophisticated buyer’s accountants will scrutinize during due diligence.

The right approach is to have an experienced sell-side advisor build the workbook with you, with each add-back documented and supported in a way that will survive the buyer’s financial review later.

The pre-sale financial review work TE conducts during practice sale preparation is built around exactly the kind of scrutiny buyers’ accountants will run, but on the seller’s side of the table, before any buyer sees the practice. Catching and addressing issues before the buyer’s audit becomes a price-cutting event mid-deal typically adds at least one additional multiple of EBITDA to the sale value.

Step 2: Decide your timeline and exit goals

The honest conversation about timing has three branches, each leading to a different optimal approach.

6-month sale window

You need or want to close within 6 months. The realistic plan: go to market with the practice as it sits today, run the competitive process efficiently, and accept the multiple your current profile supports.

Limited runway for operational improvements that would lift the multiple. The structured process still produces a meaningfully better outcome than a direct sale, but the outcome is bounded by the current state of the practice.

Twelve-to-twenty-4-month window

The window where preparation pays off. Enough time to add an associate, build management depth, clean 3 years of financials, document operational systems, and improve margin.

Each of these levers can lift the multiple. Combined, they can shift a practice from the lower end of its size tier’s range to the upper end.

Three-to-5-year window

Maximum optionality. Time to optimize for growth rate, doctor team composition, geographic expansion or facility upgrade, and to time the sale for the right point in the market cycle.

The biggest valuations get built in this window, and the upside compounds — a multiple improvement on an EBITDA base that itself grew over the same period produces dramatically more sale value than either improvement alone would suggest.

Exit goals matter alongside timing. Owners optimizing for maximum proceeds usually point toward PE-backed buyers in a competitive process.

Owners optimizing for a clean walk-away with minimal post-sale obligation usually point toward an individual buyer or smaller regional acquirer at a lower multiple but shorter employment commitment. Owners optimizing for practice culture preservation usually point toward PE-backed buyers, which generally preserve local practice branding per the patterns documented in our consolidator directory.

Most owners want some blend: meaningful proceeds, reasonable post-sale flexibility, and culture preservation. The right buyer pool and structure delivers all three when the process is run well.

Step 3: Prepare the practice

When there’s preparation time available, five operational moves move the multiple meaningfully. Per industry M&A and operations commentary including Owner Exchange and other vet operations specialists, the following levers are the most reliable.

Add an associate

A practice where 1 doctor produces 70 percent or more of revenue is structurally fragile from a buyer’s perspective. The discount applied to owner-heavy practices is roughly 1 to 2 multiples of EBITDA compared to a similar practice with diversified doctor production.

Adding an associate doesn’t fix the discount overnight — buyers typically want to see at least two and ideally three quarters of sustained associate production before they’ll credit it in the multiple. The implication: if you’re 24 months from selling, hiring an associate now is meaningful.

If you’re 12 months out, the calculus is tighter.

Build management depth

A practice that depends on the owner’s daily attention to run is, from a buyer’s perspective, a job rather than a transferable practice. The discount applied to owner-dependent practices versus practices with a real practice manager, formal roles, and documented systems is roughly 1 to 2 multiples of EBITDA.

The investment to build management depth is typically 1 to 3 percent of revenue annually, modest relative to the multiple uplift it generates.

Clean 3 years of financials

Buyers expect clear, consistent profit and loss statements with well-documented add-backs. Messy books create friction and invite skepticism during diligence.

The accounting cleanup work typically costs $5,000 to $15,000 and returns $200,000 to $500,000 in defensible EBITDA on a typical mid-market practice.

Document growth

Three consecutive years of revenue growth above 5 percent earns positive multiple adjustment from buyers. Flat revenue subtracts at least 1 multiple of EBITDA.

Declining revenue is brutal. Buyers underwrite forward — they’re paying for the projected earnings they’ll inherit and grow, not the earnings you produced last year.

Lock down real estate

If you own the practice building, buyers will value the real estate separately and the practice’s lease to itself becomes part of the deal structure. If you lease, the lease term and renewal options matter to the valuation.

A practice facing lease renewal in 2 years can see its multiple discount depending on landlord relationship quality and rent escalation provisions. Owners planning to sell often benefit from extending the lease before going to market, when the landlord has less leverage than they would once a sale is publicly being pursued.

Owners who own the building face a related decision: sell the real estate with the practice, hold the real estate and lease it back to the new owner on long-term terms, or sell the real estate separately to a real estate investor. Each path has different economic and tax implications.

The right answer depends on the seller’s broader financial picture, retirement planning, and views on the real estate market in the practice’s area. The conversation with the advisor about real estate strategy is worth having early, because some of the options take time to set up properly and the wrong default choice can quietly cost the seller several 100 thousand dollars.

Each of these moves alone produces modest multiple uplift. Combined over an 18 to 24 month window, they can transform a practice from one tier of buyer interest to another.

The compounding math is what makes preparation the highest-ROI phase in the entire process.

Step 4: Build the right buyer pool

The right buyer pool for any specific veterinary practice spans four distinct segments. The full directory of consolidators is covered in our veterinary practice consolidators guide.

PE-backed national consolidators

The largest financial buyers operating across the U.S. Per industry M&A research, this group typically targets multi-doctor practices in the $2 million-plus revenue range.

Independent PE-backed regional groups

Smaller consolidators that often pay aggressively for practices that fill specific geographic or specialty gaps in their portfolios. Their bids in competitive processes sometimes exceed the larger consolidators for the right practice profile.

Strategic local acquirers

Including Mars Veterinary Health (the strategic exception to the PE-backed pattern, per Mars company disclosures) plus neighboring multi-doctor practices that may acquire for geographic expansion.

Individual buyers and well-financed associate buyouts

Veterinarians looking to own a practice. Typically pay lower multiples than PE-backed buyers but offer cleaner exit terms.

The error most owners make in this step is narrowing the buyer pool prematurely. Two segments missing from the pool is often the difference between a good outcome and a transformative one.

The buyer most willing to pay aggressively for any specific practice is rarely identifiable from outside the competitive process.

Inside the 2-year window before selling? Get a Free Practice Value Estimate — we’ll pull your numbers, identify the right buyer pool for your profile, and send back a defensible value range with the math behind it. No upfront cost, no obligation.

Step 5: Run a structured competitive process

The Elite Selling System

Across the practices we represent, the structured competitive process we run is what we call the Elite Selling System. The name comes from how the process actually works: we hand-select and vet every buyer before they get to bid on your practice, the way a doorman with a velvet rope lets in only the right people.

The 5-step framework: speaking with you to understand the practice and your goals, building a detailed normalized valuation, hand-selecting the qualified buyers who fit your specific practice profile, running a private competitive bidding window inside that vetted group, and supporting you through due diligence and closing. The Elite Selling System is the methodology behind the outcomes documented in the case studies referenced throughout this guide — and it’s the entire reason buyers consistently pay meaningfully more inside the rope than they would in a direct conversation outside of it.

A real example from our work

A 5.5-doctor practice on the East Coast generated five competing offers ranging from $12.5 million to $22 million through our process. The owner accepted the second-highest at $20.8 million because the terms were superior — better cash at close, more favorable earnout, cleaner non-compete.

Closing was completed in 120 days. The lesson: competitive processes don’t just produce a higher headline; they produce better deals on every dimension.

This is the step that most determines the seller’s economic outcome.

The structured competitive process: a confidential information memorandum describing the practice (anonymized as needed for confidentiality) goes out to the curated buyer pool. Interested buyers sign non-disclosure agreements and receive deeper financial and operational information.

Indications of interest come in within a defined window. The strongest indications proceed to a more detailed information exchange and a competitive bidding round.

The winning bid is selected based on a combination of headline multiple, cash at close, earnout structure, rollover terms, and other deal components.

A direct sale, in contrast, looks like a one-on-one negotiation. The buyer mentions a number on the first call.

They ask for a 30-day exclusive period to “complete diligence.” During exclusivity, the seller cannot solicit other buyers. Per industry M&A commentary including Capstone Partners‘ material on pet sector deals, direct single-bidder sales typically clear at lower multiples than structured competitive processes for the same practice.

Per the practice sales we’ve run, the gap between direct-offer outcomes and competitive-process outcomes consistently runs 3 to 7 multiples of EBITDA on the headline, with additional improvement on the deal structure components. The structural difference matters as much as the headline difference for the seller’s actual proceeds.

Step 6: Negotiate the winning offer

The headline multiple is one of fifteen variables. The other fourteen frequently matter more for actual proceeds.

The components of a typical PE-backed offer (covered in depth in our PE pricing guide): cash at close, earnout consideration, rollover equity, seller notes, post-sale employment package, non-compete provisions, and a stack of legal terms covering reps and warranties, indemnification, escrow, working capital adjustments, and transition assistance. Each is negotiable separately.

Treating them as separate negotiations rather than as a single take-it-or-leave-it package is where most seller leverage lives.

The partnership or JV model — a structural choice that has become more common in 2025 and 2026. Rather than a 100 percent acquisition with rollover equity at the platform level, some PE-backed buyers offer a structure where they acquire a majority stake in the practice itself (typically 60 to 80 percent) and the seller retains 20 to 40 percent as direct equity in the practice, with a contractual put/call mechanism defining the buyout date (often year five) and a formula buyout price typically tied to the entry multiple. Per MB Law Firm’s 2025 commentary, this structure is increasingly common in healthcare and veterinary practice acquisitions.

The economic and risk profile of the partnership model is materially different from traditional rollover equity at the consolidator level. Traditional rollover ties the seller’s retained equity to the eventual exit of the entire platform, which the seller has no control over and which depends on capital markets, the platform’s overall performance, and the PE sponsor’s chosen exit timeline.

Partnership equity, by contrast, ties the seller’s retained stake to the specific practice the seller knows best, with a defined exit date and a formula price.

The honest framework for which structure better fits a specific seller starts with three questions. First, how confident are you in this specific practice’s growth trajectory over the next 5 years versus the platform’s overall trajectory?

If the practice’s outlook is stronger than the platform’s, partnership equity is more attractive. Second, how much do you value defined exit timing versus the upside of waiting for a platform exit?

Partnership equity provides defined timing; traditional rollover provides theoretically uncapped upside if the platform exit lands well. Third, how much do you want to stay engaged in running the practice over the next 5 years?

Partnership equity carries some governance rights at the practice level that traditional rollover at the consolidator level does not.

The 2026 reality is that both structures coexist across the PE-backed buyer pool. Different buyers default to different structures.

Some will offer both and let the seller choose. The right answer for any specific seller depends on practice profile, growth outlook, and personal preferences around liquidity and engagement.

Our PE pricing guide walks through the math on each in more depth.

Cash at close

Every shift from contingent payment to cash at close is real money converted from uncertain future payments to certain present payments. The competitive process is what gives the seller leverage to negotiate this dimension.

Earnout structure

Length, performance metric, threshold, and protective provisions for the seller. Shorter earnouts on metrics the seller can influence post-close (often revenue rather than EBITDA) pay out at higher realization rates than longer earnouts on metrics the buyer effectively controls.

Rollover equity

Percentage, lockup, governance rights, expected exit timeline. The terms vary significantly across buyers and across deals.

The competitive process surfaces the differences.

Non-compete scope

Geographic radius and duration. Tight non-competes can effectively end the seller’s career; reasonable ones preserve flexibility for post-sale clinical work or other professional activities.

Post-sale employment

Hours, scope, role, termination terms, compensation structure. The arrangement that PE-backed buyers typically require lasts 3 to 5 years per industry commentary.

The compensation formula determines whether the commitment period is economically meaningful or token.

Step 7: Close the transaction

Closing runs 60 to 90 days from accepted offer.

Due diligence

The buyer’s deep review of practice financials, operations, legal status, and risks. This is when the buyer’s accountants run their Quality of Earnings audit — the deep financial review they conduct to test whether the seller’s EBITDA holds up under scrutiny.

Per industry M&A commentary including Dechert LLP’s healthcare investments material, audit findings can adjust the final price 3 to 10 percent in either direction. Practices that have completed thorough pre-sale financial review during preparation typically see fewer adverse findings here.

Definitive purchase agreement

The legal document formalizing the transaction. The reps and warranties, indemnification caps, escrow provisions, and working capital adjustment formulas all hide economic value.

M&A attorneys experienced in veterinary deals are critical at this stage. Boilerplate provisions from a general business attorney usually leave value on the table.

Regulatory transfers

State veterinary board notifications, DEA registration updates, controlled substance license transfers, professional liability insurance assignment, building lease assignments. Standard process but takes 30 to 60 days and requires coordination across the closing timeline.

Integration planning

What changes day one post-close. What changes month three.

Buyer assurances about culture preservation or team continuity need to be in writing before signing. Once the seller becomes an employee of the new entity, leverage to enforce those assurances is limited.

Tax considerations that affect your actual take-home

There’s a number every vet who’s been through a sale knows that owners going into one never think about until it’s too late. The headline price your practice clears is not the number that hits your account.

The gap between gross sale value and after-tax proceeds runs into the hundreds of thousands of dollars on a typical mid-market deal, and the size of that gap is mostly determined by decisions made before the purchase agreement gets signed.

The first decision point is the structure of the transaction itself. Most veterinary practice sales close as asset sales rather than stock sales, which favors the buyer’s tax position.

The seller’s portion of the purchase price gets allocated across asset classes — equipment, goodwill, the value of the non-compete, the real estate if it’s part of the sale, working capital — and each class is taxed differently. Goodwill and going-concern value typically qualify for long-term capital gains treatment.

Equipment that’s been depreciated through the practice’s tax filings usually generates ordinary-income recapture, taxed at materially higher rates. The asset allocation negotiated into the purchase agreement is directly tied to the seller’s tax bill, and the buyer’s preferred allocation usually maximizes seller ordinary income while minimizing seller capital gains.

This allocation is negotiable in every deal. Treating it as a throwaway schedule rather than as a live negotiation is one of the more common ways owners leave money on the table after the headline number has locked in.

Per industry M&A commentary, allocation negotiations can move five or 6 percent of the headline price between buyer and seller after-tax positions.

The second decision point is the structure of the seller’s entity. A practice held in a C-corp faces a different tax profile from a practice held in an S-corp, LLC, or sole proprietorship.

C-corp sales can trigger double taxation — corporate gain on the sale, then personal gain on the distribution to the owner — unless structured carefully. Conversions and elections sometimes can and sometimes cannot be done in the time available before sale.

The conversion options that minimize double taxation typically require multiple tax years to play out, which is why owners considering a sale who hold the practice in a C-corp benefit from a conversation with their advisor and CPA at least 18 to 24 months before going to market.

The third decision point is timing. The capital gains rate that applies in the seller’s closing year matters for the after-tax outcome.

Closings near year-end versus early in the following year can shift the seller’s tax year. None of this should be the primary driver of the deal timeline, but on the margin, planned closing dates that align with the seller’s optimal tax year are worth coordinating with the advisor and CPA.

The coordination between the seller’s CPA, the M&A advisor, and a transaction-specialist tax attorney is where this work happens well or poorly. Each professional brings something the others don’t, and gaps between them are where avoidable tax dollars get lost.

The work on the front end is modest. The downstream economic value of getting it right runs reliably into the hundreds of thousands of dollars on any meaningful practice sale.

What life looks like after closing

An owner 3 months out from closing called me last quarter. He’d negotiated the deal he wanted.

The cash at close was strong. The earnout structure was reasonable.

The non-compete was tight but survivable. He had one question. What does Monday morning look like after we sign?

The transition from owner to employee of the new entity is the part of the process owners least prepare for and most often regret not thinking through. The financial deal is locked in at closing.

The day-to-day reality of the next 3 to 5 years is shaped by decisions made in the weeks before the purchase agreement is signed. Those decisions are easier to negotiate before signing than to renegotiate afterward.

Most PE-backed buyers want the selling owner to stay on as medical director or staff veterinarian for 3 to 5 years post-close. The compensation structure typically combines a base salary in line with what a hired medical director would cost, plus a production bonus tied to clinical revenue, plus participation in the practice’s profit-sharing or bonus pool.

The specific dollar figures vary materially with practice size, the selling vet’s clinical production level, and the exact structure of any retained equity.

The role itself looks different from owner work. Strategic decisions about staffing, hours, pricing, equipment investment, vendor relationships, and marketing typically shift to the consolidator’s operations team.

The selling veterinarian’s focus narrows to clinical work, mentorship, and clinical leadership of the medical team. For many owners, that shift is what they were looking for.

The operational burden of owning was exactly what they were trying to step away from, and post-close they finally get to practice medicine without simultaneously running every administrative decision. For others, the loss of decision authority feels constraining inside the first year.

The honest conversation with prospective buyers before signing about what specifically will and won’t change post-close is one of the most useful conversations a seller can have.

Culture continuity gets handled differently across buyers. The PE-backed firms covered in our consolidator directory generally preserve local practice branding, team structures, and clinical autonomy after acquisition.

Mars-owned operations historically have rebranded acquired practices more aggressively per their company disclosures. Neither pattern is absolute.

Specific buyer behavior varies practice by practice and across acquisition vintages.

Buyer assurances about culture and team continuity need to be specific, in writing, and ideally tied to defined consequences if the assurances don’t hold. The most reliable signal of how a specific buyer will treat the practice post-close is the testimony of veterinarians who sold to that buyer eighteen to 36 months ago.

Reference checks across multiple recent acquisitions are worth more than any assurance the buyer’s acquisition team makes during the courtship phase.

The vet who called me 3 months out from closing got his answer. Monday morning would look different, but the parts of the work he loved most — the clinical practice, the medicine, the team — would still be his.

The parts he was tired of would belong to someone else.

“18 months after closing, we were still happy with the choice. The buyer kept their word on the things that mattered to us — the team stayed together, the culture didn’t change overnight, and the post-sale role gave me what I wanted: clinical work without the administrative load.”

— Owner of a multi-doctor East Coast practice, sale closed 2024

The mistakes that cost owners money

Patterns I’ve seen often enough to call rules rather than tendencies.

Accepting the first direct offer from a single buyer. Per industry M&A commentary, single-bidder deals consistently land at the lower end of the multiple range. The 30-day exclusivity window many buyers request keeps the seller anchored to the initial number while the buyer’s diligence team identifies reasons it should come down.

Going to market without normalized EBITDA documented

Pricing against the P&L number rather than the normalized number leaves 15 to 30 percent of the deal on the table per industry valuation guides. The first conversation anchors the entire negotiation, and starting at the wrong number is expensive to recover from.

Signing exclusivity early

Once exclusive, the seller loses the leverage that competition provides while the buyer’s leverage compounds.

Disclosing the bottom line in negotiation

Buyers will ask what number the seller would accept. The answer is never.

Making the buyer anchor first preserves the seller’s range.

Letting the buyer dictate closing timing

Buyers want closing dates that favor their fiscal year-end and tax strategy. The seller’s tax bill is the one being optimized, so closing timing should be negotiated on terms that work for the seller.

Underestimating earnout risk

Headline earnout consideration that sounds reasonable becomes a different number when realization rates are factored in. Per industry M&A commentary, earnout realization varies widely based on the structure of the earnout.

Protective provisions and trade-offs with higher cash at close usually favor the seller.

Choosing the advisor who promises the highest number. Honest advisors tell sellers what the practice is realistically worth based on profile and process. Less reliable advisors promise inflated numbers to win the engagement, then revise expectations downward after signing.

Asking for case data and references from owners who closed deals through the advisor is the most reliable filter.

When deals fall apart and how to prevent it

Most well-run practice sales close. Some don’t.

The deals that fall apart typically fail in one of five places, and the failures are largely preventable with disciplined preparation and process management.

Financial diligence findings that materially change the buyer’s underwriting. The single most common cause of post-LOI deal renegotiation or termination. The buyer’s accountants find that normalized EBITDA was overstated, that one-time items weren’t actually one-time, that revenue concentration is more concentrated than the seller represented, or that the recent growth was driven by factors that won’t continue post-close.

The repair: thorough pre-sale financial review on the seller’s side of the table, conducted by an advisor who anticipates exactly what the buyer’s audit team will look at, before any buyer sees the practice.

Legal or regulatory issues surfacing during due diligence. Compliance gaps, pending or threatened litigation, employee misclassification, controlled-substance documentation problems, lease or real-estate complications. The repair: legal review during practice sale preparation, ideally with a healthcare M&A attorney who has cleared similar transactions recently.

Real estate complications

Lease assignment denials by the landlord, short remaining lease terms, environmental concerns at owned properties, or zoning restrictions affecting facility expansion plans. The repair: real estate documentation review during preparation, with lease extension or modification negotiated before going to market when possible.

Buyer financing or platform issues

Less common but consequential. The buyer’s debt facility tightens, a portfolio-level issue at the platform reduces the buyer’s capacity to close, or the buyer’s investment committee revises target multiples mid-process.

The repair: a structured competitive process with multiple qualified bidders preserves the seller’s optionality if a primary bidder pulls back. A direct sale with no backup buyer is much harder to recover from when the primary buyer can’t close.

Owner cold feet

Owners sometimes reconsider during the diligence period, especially as the post-sale role and culture changes come into focus. The repair: honest conversations during preparation about what the post-sale period will realistically look like, with the buyer’s team and with the advisor.

Owners who walk into a sale with clear expectations rarely reverse course mid-process. Owners who avoid those conversations until the eleventh hour are the ones who pull back late.

The pattern across all five failure modes: nearly every preventable cause traces back to preparation work that should have been done before the buyer saw the practice. The twelve-to-twenty-4-month preparation window is where most deal-killing problems get identified and addressed.

The advisors I trust most are the ones who run that preparation work seriously, because the work done before listing is what makes the work after listing close cleanly.

What separates deals that clear at the top of the range

Three things, all of which compound and all of which require time to set up properly.

Documentation rigor

Normalized EBITDA built on defensible add-backs. 3 years of clean P&Ls. Doctor productivity reports.

Operational systems documented. Buyer’s accountants find nothing during their financial review that disrupts the negotiation because everything was already addressed during practice sale preparation.

Process discipline

No exclusivity granted prematurely. No buyer pool narrowing until the competitive process has surfaced the most willing bidder.

Bidding window respected. Information flow controlled.

Multiple bidders underwriting in parallel until the winning bid is selected on the full package, not just the headline.

Negotiation across all components

Cash at close, earnout, rollover, partnership versus traditional structure choice, non-compete, post-sale employment, definitive agreement provisions, regulatory transfers, integration planning. Treating each as a separate negotiation rather than as a single bundle.

The Transitions Elite engagement model is built around delivering all three of these consistently. The combination is what produces outcomes meaningfully above what direct sales typically clear, and the difference compounds across deal components.

“Transitions Elite holds your hand and guides you through the whole process. Even though it’s a stressful time and situation, they make selling so easy.”

— Dr. Lonnie & Naomi Davis, Ohio

What to do if you’re considering selling in 2026

Three concrete steps for any vet inside the 2-year window before sale.

One: get a defensible normalized EBITDA number documented. Not next year. This quarter.

The number drives every downstream decision, and getting it built properly with an experienced advisor typically takes 30 to 60 days. The owners who walk into a sale with that number documented and supported clear meaningfully more than the owners who anchor to the raw P&L.

Two: do not sign exclusivity with the first buyer who calls. If a buyer has already reached out and asked for exclusivity, the right answer is to politely defer and engage a sell-side advisor before responding further. The buyer that called can absolutely be part of the eventual competitive process — they will just have to compete for the practice on the same terms as their peers.

Three: get an honest read on what your specific practice would actually clear in a competitive process. Not what the buyer who called teased on the first conversation. The real number, with the math behind it.

Get a Free Practice Value Estimate →

Send us your practice profile — revenue, EBITDA, doctor count, geography, specialty mix, real estate ownership, growth trajectory. We will build the normalized EBITDA properly, identify the right buyer pool for your specific situation, and send you back a defensible value range with the math behind it.

The estimate is free and there’s no obligation to engage further. The Transitions Elite engagement model is success-based — no upfront fees, no retainer.

We only get paid when a deal closes, and only out of the value our process delivers above what you would have realized on your own.

---

Further reading

These are the related TE resources covering the topics adjacent to the sale process itself.

• Veterinary practice EBITDA multiples in 2026 — what your practice will actually sell for, by size and profile.
• How much private equity is paying for veterinary practices — the PE business model, deal structure mechanics, and what each component of an offer is really worth.
• Veterinary practice consolidators directory — every major buyer operating in the market in 2026, with ownership and scale per buyer.
• Selling your veterinary practice to NVA — the buyer-specific deep dive on National Veterinary Associates.
• Our practice sale results — case studies of practices we’ve represented and outcomes.
• About Transitions Elite — the team and methodology.

Frequently asked questions

How long does it take to sell a veterinary practice?

From the engagement of a sell-side advisor to closing, the typical timeline for a competitive sale process is 5 to 10 months. The competitive bidding phase alone runs 14 to 60 days.

Owners benefit from starting practice preparation 12 to 24 months before listing.

What is the first step in selling a veterinary practice?

Documenting a defensible normalized EBITDA figure. Per industry valuation guides, buyers price practices against the normalized number rather than the raw P&L.

Documented normalization typically raises the EBITDA figure 15 to 30 percent above the tax-return number.

Do I need a veterinary practice broker to sell my practice?

Legally, no. Practically, the economics generally favor working with an experienced sell-side advisor for any practice above approximately $2 million in revenue.

Most reputable veterinary M&A advisors work on a success-based engagement model with no upfront fees.

What’s the difference between selling to a private equity buyer and an individual buyer?

PE-backed buyers typically pay higher multiples but use deal structures with earnouts, rollover equity, and 3 to 5 year post-sale employment commitments. Individual buyers typically pay lower multiples but offer cleaner exits.

What documents do I need to sell my veterinary practice?

3 years of profit and loss statements and tax returns, a documented normalized EBITDA workbook, equipment inventory, lease agreements, employee roster with compensation, doctor productivity reports, vendor contracts, and patient retention data.

Can I continue practicing veterinary medicine after I sell my practice?

Yes. PE-backed buyers typically require selling owners to stay on as medical director or staff veterinarian for 3 to 5 years post-close.

Individual buyers may want shorter consulting arrangements.

What’s the most common mistake veterinary practice owners make when selling?

Accepting the first direct offer from a buyer without exploring the broader buyer pool through a competitive process. Single-bidder sales consistently produce lower outcomes than structured competitive processes for the same practice.

When is the best time to start preparing to sell my veterinary practice?

Per industry M&A commentary, owners typically benefit from starting preparation 18 to 24 months before going to market. The preparation window is where the highest-impact operational improvements get made.

What are the tax implications of selling a veterinary practice?

Most sales close as asset sales with the purchase price allocated across asset classes that are taxed differently. Goodwill typically qualifies for long-term capital gains; equipment generates ordinary-income recapture.

The asset allocation is negotiable. Practices held in C-corps face additional tax complexity that often requires entity restructuring 18 to 24 months before sale.

Coordination between the seller’s CPA, M&A advisor, and a transaction-specialist tax attorney is where the after-tax outcome gets built.

What happens to my staff after I sell my veterinary practice?

PE-backed buyers typically retain the existing practice team and preserve local branding after acquisition. Mars-owned operations historically have rebranded more aggressively.

Specific buyer behavior varies practice by practice. The most reliable signal is reference checks with veterinarians who sold to that buyer 18 to 36 months ago.

Buyer assurances about team continuity should be specific and in writing.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion.” 2025. octus.com
3. Total Practice Solutions Group. “Understanding Veterinary Practice Valuations.” totalpracticesolutionsgroup.com

Veterinary practice operations, benchmarks, and profession data

4. iVET360. “Understanding Your Animal Hospital’s EBITDA.” ivet360.com
5. Owner Exchange. “Veterinary Clinic Profitability Insights.” ownerexchange.com
6. AVMA. “Just released: AVMA data and insights on the veterinary profession.” avma.org

Legal, regulatory, and transaction-process analysis

7. Mahan Law. “Timeline and Process for Selling a Veterinary Practice.” mahanlaw.com
8. Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com
9. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” 2026. hklaw.com